المؤلفون: Clarke P., Dalbeth N., Day R.O., De Zoysa J.R., Douglas B., Perkovic V., Rangan G.K., Reidlinger D., Robison L., Walker R.J., Walters G., Johnson D.W., Badve S.V., Pascoe E.M., Tiku A., Boudville N., Brown F.G., Cass A., Faull R., Harris D.C., Hawley C.M., Jones G.R.D., Kanellis J., Palmer S.C.

مصطلحات الفهرس: uric acid blood level, allopurinol/ae [Adverse Drug Reaction], allopurinol/ct [Clinical Trial], allopurinol/cm [Drug Comparison], allopurinol/dt [Drug Therapy], allopurinol/po [Oral Drug Administration], allopurinol/pd [Pharmacology], placebo, uric acid/ec [Endogenous Compound], endocrine disease/si [Side Effect], adult, albumin to creatinine ratio, aplastic anemia/si [Side Effect], article, body surface, cardiovascular disease/si [Side Effect], chronic kidney failure/dt [Drug Therapy], clinical outcome, controlled clinical trial, controlled study, disease course, double blind procedure, DRESS syndrome/si [Side Effect], drug dose escalation, drug effect, drug safety, epidermolysis/si [Side Effect], erythema multiforme/si [Side Effect], estimated glomerular filtration rate, female, gastrointestinal disease/si [Side Effect], hematologic disease/si [Side Effect], human, kidney disease/si [Side Effect], major clinical study, male, malignant neoplasm/si [Side Effect], musculoskeletal disease/si [Side Effect], neurologic disease/si [Side Effect], priority journal, randomized controlled trial, rash/si [Side Effect], respiratory tract disease/si [Side Effect], skin disease/si [Side Effect], Stevens Johnson syndrome/si [Side Effect], thrombocytopenia/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29054
New England Journal of Medicine
Click here for full text options
LibKey Link

المؤلفون: Subramaniam K., Svenningsen L., Baekdal M., Kammerlander H., Walsh A., Boysen T., Bampton P., Radford-Smith G., Kjeldsen J., Andrews J.M., Vestergaard T., Moore G.T., Jensen N.M., Connor S.J., Wildt S., Wilson B., Ellard K., Christensen L.A., Bell S.J., Julsgaard M., Hvas C.L., Gearry R.B., Gibson P.R., Fallingborg J., Sparrow M.P., Bibby B.M., Connell W.R., Brown S.J., Kamm M.A., Lawrance I.C.

مصطلحات الفهرس: budesonide/pv [Special Situation for Pharmacovigilance], infliximab/cb [Drug Combination], infliximab/cm [Drug Comparison], infliximab/dt [Drug Therapy], infliximab/pv [Special Situation for Pharmacovigilance], mercaptopurine/cb [Drug Combination], mercaptopurine/dt [Drug Therapy], mercaptopurine/pv [Special Situation for Pharmacovigilance], mesalazine/pv [Special Situation for Pharmacovigilance], prednisolone/dt [Drug Therapy], prednisolone/pv [Special Situation for Pharmacovigilance], tumor necrosis factor antibody/cb [Drug Combination], tumor necrosis factor antibody/dt [Drug Therapy], tumor necrosis factor antibody/to [Drug Toxicity], tumor necrosis factor antibody/pv [Special Situation for Pharmacovigilance], mesalazine/dt [Drug Therapy], adult, adverse outcome, article, attitude to illness, Australia, cohort analysis, controlled study, Crohn disease/dt [Drug Therapy], Denmark, disease activity, female, fetus, gestational age, human, inflammatory bowel disease/dt [Drug Therapy], low birth weight, major clinical study, male, medical information, New Zealand, newborn, patient counseling, patient satisfaction, prediction, pregnancy outcome, pregnant woman, priority journal, prospective study, questionnaire, recurrence risk, risk assessment, third trimester pregnancy, treatment response, ulcerative colitis/dt [Drug Therapy], adalimumab/cb [Drug Combination], adalimumab/cm [Drug Comparison], adalimumab/dt [Drug Therapy], adalimumab/pv [Special Situation for Pharmacovigilance], allopurinol/cb [Drug Combination], allopurinol/dt [Drug Therapy], allopurinol/pv [Special Situation for Pharmacovigilance], budesonide/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29311
Inflammatory Bowel Diseases
Click here for full text options
LibKey Link

المؤلفون: Clarke P., Dalbeth N., Day R.O., De Zoysa J.R., Douglas B., Perkovic V., Rangan G.K., Reidlinger D., Robison L., Walker R.J., Walters G., Johnson D.W., Badve S.V., Pascoe E.M., Tiku A., Boudville N., Brown F.G., Cass A., Faull R., Harris D.C., Hawley C.M., Jones G.R.D., Kanellis J., Palmer S.C.

مصطلحات الفهرس: uric acid blood level, allopurinol/ae [Adverse Drug Reaction], allopurinol/ct [Clinical Trial], allopurinol/cm [Drug Comparison], allopurinol/dt [Drug Therapy], allopurinol/po [Oral Drug Administration], allopurinol/pd [Pharmacology], placebo, uric acid/ec [Endogenous Compound], endocrine disease/si [Side Effect], adult, albumin to creatinine ratio, aplastic anemia/si [Side Effect], article, body surface, cardiovascular disease/si [Side Effect], chronic kidney failure/dt [Drug Therapy], clinical outcome, controlled clinical trial, controlled study, disease course, double blind procedure, DRESS syndrome/si [Side Effect], drug dose escalation, drug effect, drug safety, epidermolysis/si [Side Effect], erythema multiforme/si [Side Effect], estimated glomerular filtration rate, female, gastrointestinal disease/si [Side Effect], hematologic disease/si [Side Effect], human, kidney disease/si [Side Effect], major clinical study, male, malignant neoplasm/si [Side Effect], musculoskeletal disease/si [Side Effect], neurologic disease/si [Side Effect], priority journal, randomized controlled trial, rash/si [Side Effect], respiratory tract disease/si [Side Effect], skin disease/si [Side Effect], Stevens Johnson syndrome/si [Side Effect], thrombocytopenia/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29054
New England Journal of Medicine
LibKey Link

المؤلفون: Subramaniam K., Svenningsen L., Baekdal M., Kammerlander H., Walsh A., Boysen T., Bampton P., Radford-Smith G., Kjeldsen J., Andrews J.M., Vestergaard T., Moore G.T., Jensen N.M., Connor S.J., Wildt S., Wilson B., Ellard K., Christensen L.A., Bell S.J., Julsgaard M., Hvas C.L., Gearry R.B., Gibson P.R., Fallingborg J., Sparrow M.P., Bibby B.M., Connell W.R., Brown S.J., Kamm M.A., Lawrance I.C.

مصطلحات الفهرس: budesonide/pv [Special Situation for Pharmacovigilance], infliximab/cb [Drug Combination], infliximab/cm [Drug Comparison], infliximab/dt [Drug Therapy], infliximab/pv [Special Situation for Pharmacovigilance], mercaptopurine/cb [Drug Combination], mercaptopurine/dt [Drug Therapy], mercaptopurine/pv [Special Situation for Pharmacovigilance], mesalazine/pv [Special Situation for Pharmacovigilance], prednisolone/dt [Drug Therapy], prednisolone/pv [Special Situation for Pharmacovigilance], tumor necrosis factor antibody/cb [Drug Combination], tumor necrosis factor antibody/dt [Drug Therapy], tumor necrosis factor antibody/to [Drug Toxicity], tumor necrosis factor antibody/pv [Special Situation for Pharmacovigilance], mesalazine/dt [Drug Therapy], adult, adverse outcome, article, attitude to illness, Australia, cohort analysis, controlled study, Crohn disease/dt [Drug Therapy], Denmark, disease activity, female, fetus, gestational age, human, inflammatory bowel disease/dt [Drug Therapy], low birth weight, major clinical study, male, medical information, New Zealand, newborn, patient counseling, patient satisfaction, prediction, pregnancy outcome, pregnant woman, priority journal, prospective study, questionnaire, recurrence risk, risk assessment, third trimester pregnancy, treatment response, ulcerative colitis/dt [Drug Therapy], adalimumab/cb [Drug Combination], adalimumab/cm [Drug Comparison], adalimumab/dt [Drug Therapy], adalimumab/pv [Special Situation for Pharmacovigilance], allopurinol/cb [Drug Combination], allopurinol/dt [Drug Therapy], allopurinol/pv [Special Situation for Pharmacovigilance], budesonide/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29311
Inflammatory Bowel Diseases
LibKey Link

المؤلفون: Lai F.Y.X., Junckerstorff R., Chee A., Goh C.L.

مصطلحات الفهرس: letter, male, middle aged, non insulin dependent diabetes mellitus, positron emission tomography-computed tomography, priority journal, tertiary care center, uric acid blood level, weakness, allopurinol/dt [Drug Therapy], C reactive protein/ec [Endogenous Compound], colchicine/dt [Drug Therapy], prednisolone/dt [Drug Therapy], urate/ec [Endogenous Compound], uric acid/ec [Endogenous Compound], nuclear magnetic resonance imaging, adult, arthritis, Australia, backache, case report, clinical article, clinical examination, fever, gout/di [Diagnosis], gout/dt [Drug Therapy], human, hypotension, joint effusion, knee pain, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/37504
Internal Medicine Journal
Click here for full text options
LibKey Link

المؤلفون: Lai F.Y.X., Junckerstorff R., Chee A., Goh C.L.

مصطلحات الفهرس: letter, male, middle aged, non insulin dependent diabetes mellitus, positron emission tomography-computed tomography, priority journal, tertiary care center, uric acid blood level, weakness, allopurinol/dt [Drug Therapy], C reactive protein/ec [Endogenous Compound], colchicine/dt [Drug Therapy], prednisolone/dt [Drug Therapy], urate/ec [Endogenous Compound], uric acid/ec [Endogenous Compound], nuclear magnetic resonance imaging, adult, arthritis, Australia, backache, case report, clinical article, clinical examination, fever, gout/di [Diagnosis], gout/dt [Drug Therapy], human, hypotension, joint effusion, knee pain, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/37504
Internal Medicine Journal
Click here for full text options
LibKey Link

المؤلفون: Moore G.T., Corte C., Katelaris P., Leong R.W., Gounder P., Collins G., Walsh A.J., Connor S., Lee T.W.T., Koh C.E., Chang J., Paramsothy S., Tattersall S., Lemberg D.A., Radford-Smith G., Lawrance I.C., McLachlan A., Chen J.-H., Andrews J.M., Kariyawasam V., Moran N.

مصطلحات الفهرس: ulcerative colitis/dt [Drug Therapy], venous thromboembolism/co [Complication], venous thromboembolism/pc [Prevention], adalimumab/dt [Drug Therapy], allopurinol/dt [Drug Therapy], cyclosporin A/dt [Drug Therapy], golimumab/dt [Drug Therapy], hydrocortisone/dt [Drug Therapy], hydrocortisone/iv [Intravenous Drug Administration], infliximab/cb [Drug Combination], infliximab/dt [Drug Therapy], mercaptopurine/cb [Drug Combination], mercaptopurine/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], vedolizumab/dt [Drug Therapy], acute severe ulcerative colitis/co [Complication], acute severe ulcerative colitis/dt [Drug Therapy], acute severe ulcerative colitis/pc [Prevention], acute severe ulcerative colitis/su [Surgery], cytomegalovirus colitis/di [Diagnosis], acute severe ulcerative colitis/di [Diagnosis], human, acute disease/co [Complication], acute disease/di [Diagnosis], acute disease/dt [Drug Therapy], acute disease/pc [Prevention], acute disease/su [Surgery], article, Australia, clinical practice, colitis/di [Diagnosis], colon resection, consensus, Delphi study, differential diagnosis, disease severity, drug response, drug treatment failure, evidence based medicine, hospitalization, maintenance therapy, mortality, patient care, patient monitoring, priority journal, sigmoidoscopy, systematic review, thrombosis prevention, ulcerative colitis/di [Diagnosis], ulcerative colitis/pc [Prevention], ulcerative colitis/su [Surgery], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39590
Alimentary Pharmacology and Therapeutics
Click here for full text options
LibKey Link

المؤلفون: Moore G.T., Corte C., Katelaris P., Leong R.W., Gounder P., Collins G., Walsh A.J., Connor S., Lee T.W.T., Koh C.E., Chang J., Paramsothy S., Tattersall S., Lemberg D.A., Radford-Smith G., Lawrance I.C., McLachlan A., Chen J.-H., Andrews J.M., Kariyawasam V., Moran N.

مصطلحات الفهرس: ulcerative colitis/dt [Drug Therapy], venous thromboembolism/co [Complication], venous thromboembolism/pc [Prevention], adalimumab/dt [Drug Therapy], allopurinol/dt [Drug Therapy], cyclosporin A/dt [Drug Therapy], golimumab/dt [Drug Therapy], hydrocortisone/dt [Drug Therapy], hydrocortisone/iv [Intravenous Drug Administration], infliximab/cb [Drug Combination], infliximab/dt [Drug Therapy], mercaptopurine/cb [Drug Combination], mercaptopurine/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], vedolizumab/dt [Drug Therapy], acute severe ulcerative colitis/co [Complication], acute severe ulcerative colitis/dt [Drug Therapy], acute severe ulcerative colitis/pc [Prevention], acute severe ulcerative colitis/su [Surgery], cytomegalovirus colitis/di [Diagnosis], acute severe ulcerative colitis/di [Diagnosis], human, acute disease/co [Complication], acute disease/di [Diagnosis], acute disease/dt [Drug Therapy], acute disease/pc [Prevention], acute disease/su [Surgery], article, Australia, clinical practice, colitis/di [Diagnosis], colon resection, consensus, Delphi study, differential diagnosis, disease severity, drug response, drug treatment failure, evidence based medicine, hospitalization, maintenance therapy, mortality, patient care, patient monitoring, priority journal, sigmoidoscopy, systematic review, thrombosis prevention, ulcerative colitis/di [Diagnosis], ulcerative colitis/pc [Prevention], ulcerative colitis/su [Surgery], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39590
Alimentary Pharmacology and Therapeutics
LibKey Link

المؤلفون: Buchbinder R., Whittle S.L., Wechalekar M.D., Moi J.H.Y., Barrett C., Hill C.L., Littlejohn G., Lynch N., Major G., Taylor A.L., Graf S.W., Zochling J.

مصطلحات الفهرس: human, systematic review, allopurinol/dt [Drug Therapy], azathioprine/dt [Drug Therapy], benzbromarone/dt [Drug Therapy], colchicine/dt [Drug Therapy], glucocorticoid/dt [Drug Therapy], nonsteroid antiinflammatory agent/dt [Drug Therapy], probenecid/dt [Drug Therapy], uricosuric agent/dt [Drug Therapy], arthropathy, article, Australian, clinical practice, clinical trial (topic), Cochrane Library, comorbidity, data extraction, data synthesis, Embase, gout/di [Diagnosis], gout/dt [Drug Therapy], hyperuricemia, joint aspiration, Medline, New Zealand, priority journal, rheumatology, statistical bias, febuxostat/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40789
International Journal of Rheumatic Diseases
Click here for full text options
LibKey Link

المؤلفون: Buchbinder R., Whittle S.L., Wechalekar M.D., Moi J.H.Y., Barrett C., Hill C.L., Littlejohn G., Lynch N., Major G., Taylor A.L., Graf S.W., Zochling J.

مصطلحات الفهرس: human, systematic review, allopurinol/dt [Drug Therapy], azathioprine/dt [Drug Therapy], benzbromarone/dt [Drug Therapy], colchicine/dt [Drug Therapy], glucocorticoid/dt [Drug Therapy], nonsteroid antiinflammatory agent/dt [Drug Therapy], probenecid/dt [Drug Therapy], uricosuric agent/dt [Drug Therapy], arthropathy, article, Australian, clinical practice, clinical trial (topic), Cochrane Library, comorbidity, data extraction, data synthesis, Embase, gout/di [Diagnosis], gout/dt [Drug Therapy], hyperuricemia, joint aspiration, Medline, New Zealand, priority journal, rheumatology, statistical bias, febuxostat/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40789
International Journal of Rheumatic Diseases
LibKey Link

المؤلفون: Walters G., Perkovic V., Pascoe E.M., Rangan G.K., Walker R.J., Johnson D.W., Bose B., Badve S.V., Hiremath S.S., Boudville N., Brown F.G., Cass A., De Zoysa J.R., Fassett R.G., Faull R., Harris D.C., Hawley C.M., Kanellis J., Palmer S.C.

مصطلحات الفهرس: death, drug efficacy, drug safety, end stage renal disease, glomerulus filtration rate, human, kidney function, major clinical study, meta analysis, priority journal, proteinuria, randomized controlled trial, rash/si [Side Effect], review, risk benefit analysis, Stevens Johnson syndrome/si [Side Effect], thrombocytopenia/si [Side Effect], toxic epidermal necrolysis/si [Side Effect], uric acid blood level, allopurinol/ae [Adverse Drug Reaction], allopurinol/dt [Drug Therapy], creatinine/ec [Endogenous Compound], placebo, uric acid/ec [Endogenous Compound], allopurinol/ct [Clinical Trial], aplastic anemia/si [Side Effect], blood pressure, chronic kidney disease/dt [Drug Therapy], controlled study, creatinine blood level, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/42016
Click here for full text options
LibKey Link

المؤلفون: Walters G., Perkovic V., Pascoe E.M., Rangan G.K., Walker R.J., Johnson D.W., Bose B., Badve S.V., Hiremath S.S., Boudville N., Brown F.G., Cass A., De Zoysa J.R., Fassett R.G., Faull R., Harris D.C., Hawley C.M., Kanellis J., Palmer S.C.

مصطلحات الفهرس: death, drug efficacy, drug safety, end stage renal disease, glomerulus filtration rate, human, kidney function, major clinical study, meta analysis, priority journal, proteinuria, randomized controlled trial, rash/si [Side Effect], review, risk benefit analysis, Stevens Johnson syndrome/si [Side Effect], thrombocytopenia/si [Side Effect], toxic epidermal necrolysis/si [Side Effect], uric acid blood level, allopurinol/ae [Adverse Drug Reaction], allopurinol/dt [Drug Therapy], creatinine/ec [Endogenous Compound], placebo, uric acid/ec [Endogenous Compound], allopurinol/ct [Clinical Trial], aplastic anemia/si [Side Effect], blood pressure, chronic kidney disease/dt [Drug Therapy], controlled study, creatinine blood level, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/42016
Click here for full text options
LibKey Link

المؤلفون: Kanellis J., Feig D.I., Johnson R.J.

مصطلحات الفهرس: renin angiotensin aldosterone system, review, uric acid blood level, vascular smooth muscle, allopurinol/cm [Drug Comparison], allopurinol/dt [Drug Therapy], allopurinol/pd [Pharmacology], atenolol/cm [Drug Comparison], atenolol/dt [Drug Therapy], benziodarone/cm [Drug Comparison], benziodarone/dt [Drug Therapy], beta adrenergic receptor blocking agent/cm [Drug Comparison], beta adrenergic receptor blocking agent/dt [Drug Therapy], cyclosporin/to [Drug Toxicity], dipeptidyl carboxypeptidase inhibitor/cm [Drug Comparison], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], diuretic agent/dt [Drug Therapy], hypoxanthine, losartan/cm [Drug Comparison], losartan/dt [Drug Therapy], losartan/pd [Pharmacology], mitogen activated protein kinase, monocyte chemotactic protein, platelet derived growth factor, prostaglandin synthase, purine, superoxide, urate oxidase, xanthine, xanthine oxidase, uric acid, atherosclerosis, cardiovascular disease/dt [Drug Therapy], cell proliferation, enzyme activation, enzyme degradation, glomerulus filtration rate, human, hypertension/dt [Drug Therapy], hyperuricemia/dt [Drug Therapy], kidney disease/dt [Drug Therapy], nephrotoxicity, nonhuman, priority journal, protein expression, purine metabolism, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32529
Click here for full text options
LibKey Link

المؤلفون: Kanellis J., Feig D.I., Johnson R.J.

مصطلحات الفهرس: renin angiotensin aldosterone system, review, uric acid blood level, vascular smooth muscle, allopurinol/cm [Drug Comparison], allopurinol/dt [Drug Therapy], allopurinol/pd [Pharmacology], atenolol/cm [Drug Comparison], atenolol/dt [Drug Therapy], benziodarone/cm [Drug Comparison], benziodarone/dt [Drug Therapy], beta adrenergic receptor blocking agent/cm [Drug Comparison], beta adrenergic receptor blocking agent/dt [Drug Therapy], cyclosporin/to [Drug Toxicity], dipeptidyl carboxypeptidase inhibitor/cm [Drug Comparison], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], diuretic agent/dt [Drug Therapy], hypoxanthine, losartan/cm [Drug Comparison], losartan/dt [Drug Therapy], losartan/pd [Pharmacology], mitogen activated protein kinase, monocyte chemotactic protein, platelet derived growth factor, prostaglandin synthase, purine, superoxide, urate oxidase, xanthine, xanthine oxidase, uric acid, atherosclerosis, cardiovascular disease/dt [Drug Therapy], cell proliferation, enzyme activation, enzyme degradation, glomerulus filtration rate, human, hypertension/dt [Drug Therapy], hyperuricemia/dt [Drug Therapy], kidney disease/dt [Drug Therapy], nephrotoxicity, nonhuman, priority journal, protein expression, purine metabolism, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32529
LibKey Link

المؤلفون: Spernat D., Kourambas J.

مصطلحات الفهرس: kidney colic/dt [Drug Therapy], kidney colic/th [Therapy], low fat diet, mental health, nephrotic syndrome/si [Side Effect], pancytopenia/si [Side Effect], priority journal, prophylaxis, protein restriction, purine metabolism, rash/si [Side Effect], recurrent disease/dt [Drug Therapy], recurrent disease/pc [Prevention], risk reduction, side effect/si [Side Effect], sodium restriction, stone dissolution, stone formation/dt [Drug Therapy], stone formation/pc [Prevention], thrombosis/si [Side Effect], ureter stone/dt [Drug Therapy], urolithiasis/dt [Drug Therapy], urolithiasis/th [Therapy], weight reduction, acetohydroxamic acid/ae [Adverse Drug Reaction], acetohydroxamic acid/dt [Drug Therapy], alfuzosin/cm [Drug Comparison], alfuzosin/dt [Drug Therapy], allopurinol/dt [Drug Therapy], alpha adrenergic receptor blocking agent/cm [Drug Comparison], alpha adrenergic receptor blocking agent/dt [Drug Therapy], bicarbonate/dt [Drug Therapy], bicarbonate/po [Oral Drug Administration], calcium/ec [Endogenous Compound], calcium channel blocking agent/dt [Drug Therapy], cellulose phosphate/ae [Adverse Drug Reaction], cellulose phosphate/dt [Drug Therapy], citrate potassium/ae [Adverse Drug Reaction], citrate potassium/cb [Drug Combination], citrate potassium/dt [Drug Therapy], citrate potassium/po [Oral Drug Administration], citric acid/dt [Drug Therapy], corticosteroid/cm [Drug Comparison], corticosteroid/dt [Drug Therapy], deflazacort/cm [Drug Comparison], deflazacort/dt [Drug Therapy], doxazosin/cm [Drug Comparison], doxazosin/dt [Drug Therapy], nifedipine/ct [Clinical Trial], nifedipine/cm [Drug Comparison], nifedipine/dt [Drug Therapy], nonsteroid antiinflammatory agent/dt [Drug Therapy], oxalic acid/ec [Endogenous Compound], penicillamine/ae [Adverse Drug Reaction], penicillamine/cm [Drug Comparison], penicillamine/dt [Drug Therapy], placebo, potassium dihydrogen phosphate/dt [Drug Therapy], scopolamine butyl bromide, tamsulosin/ct [Clinical Trial], tamsulosin/cm [Drug Comparison], tamsulosin/dt [Drug Therapy], terazosin/cm [Drug Comparison], terazosin/dt [Drug Therapy], thiazide diuretic agent/cb [Drug Combination], thiazide diuretic agent/dt [Drug Therapy], tiopronin/ae [Adverse Drug Reaction], tiopronin/cm [Drug Comparison], trometamol/dt [Drug Therapy], uric acid/ec [Endogenous Compound], tiopronin/dt [Drug Therapy], bone pain/si [Side Effect], acid secretion, article, asthenia/si [Side Effect], calcium intake, calcium oxalate stone/dt [Drug Therapy], calcium urine level, cystinuria/dt [Drug Therapy], dermatitis/si [Side Effect], fluid intake, gastrointestinal symptom/si [Side Effect], human, hypercalciuria/dt [Drug Therapy], hypocoagulability/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30184
LibKey Link